← All candidates
56 insider filings on record.
56 filings on record.
BCYCBICYCLE THERAPEUTICS PLC
NasdaqGS · Healthcare · $270.17M
$3.86
+1.24% today
56 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 26 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$270.17M
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
4.4
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
51 more transactions on Pro →Context
Wall St
$12.63 avg target
+227.1% vs today · 8 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.87 act−$0.20
Q4 '25−$0.29 act+$0.66
Q3 '25−$0.85 act+$0.22
Q2 '25−$1.14 act−$0.21
Coverage
Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline RefocusInsider Monkey · 04-17Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?Zacks · 07-03European Equities Traded in the US as American Depositary Receipts Rise in Tuesday TradingMT Newswires · 06-30European Equities Traded in the US as American Depositary Receipts Rise in Wednesday TradingMT Newswires · 06-17
The file stays open
56 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice